PUBLIC CONTRACT · 2021
4180118/2021 - Aq. Central A5350 - Adalimumab 40 mg (100 mg/ml caneta 0.4 ml) sol inj
- Contract value
- €19,200.00
- Signed on
- 2 February 2021
- Procedure
- Ao abrigo de acordo-quadro (art.º 258.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 7493758PUBLISHED SUBJECT
4180118/2021 - AQ. CENTRAL A5350 - ADALIMUMAB 40 MG (100 MG/ML CANETA 0.4 ML) SOL INJ
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- AbbVie, LDA · Tax ID 510229050
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €19,200.00
- Procedure base price
- €19,200.00
- Total effective price
- €19,200.00
- Publication date
- 22 February 2021
- Award date
- 2 February 2021
- Signing date
- 2 February 2021
- Performance period
- 20 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 258.º)
- Award criterion
- Melhor relação qualidade – preço
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 258.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2015/64 - Medicamentos Diversos
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 5152988
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.